Zum Seiteninhalt springen

In his keynote on the basics, horizon, and future of AI and its applications in the regenerative medicine and pharma, Prof. Stefano Bini, UCSF Medical Center, set the context for the forum and outlined major current uses of AI in orthopedics and beyond but also the importance of data collection, standardization, and accessibility.

Carsten Marr. Helmholtz Center Munich, seeks to advance the understanding and diagnosis of serious blood diseases. To this end, he develops customised machine learning algorithms to classify individual cells. In his talk “AI for the High-Throughput Single Cell Analysis of Pancreatic Progenitors” he gave an insight into how the power of AI can be combined with the knowledge on biomedical systems.

Petra Ritter, Charité – Universitätsmedizin Berlin & BIH showed in an impressive way how the latest breakthroughs in computational neuroscience are revolutionising the diagnosis and treatment of brain diseases by using “Digital Twins of Human Brains”.

Elsa Kirchner, University of Duisburg-Essen & German Research Center for Artificial Intelligence (DFKI) showed some impressive results on how exoscelletons are being used in cutting-edge research and also in first clinical applications.

Examples of the use of AI in the clinic was among others given by Tabea Flügge Charité – Universitätsmedizin Berlin, Einstein Center Digital Future, and showed the usage of advanced image reconstruction methods to enable personalised face reconstruction for complex cases. Use cases to boost regeneration for the importance of AI in the translational process from bench to bedside were introduced by Georg Duda, BCRT.

The views of the industry on the use of AI was given by Julia Hoxha, Zana Technologies GmbH,and Philipp Koch, Limebit GmbH. Julia Hoxha gave insights into the usage of an AI driven patient engagement platform that can assist the active engagement and empowerment of patients in clinical trials.

Anne Schwerk, Head of Science Center Management at the BCRT moderated the event and led the panel discussion that reviewed the major open questions in the field discussed by Stefano BiniMaike Sander, director of the Max Delbrück Center for Molecular Medicine, Petra Ritter (BIH Johanna Quandt Professor of Brain Simulation) and Roland Roller (German Research Center for Artificial Intelligence), including  topics such as missing access to data or the need of a new educational system to include more IT/Data literacy. Moreover, they all agreed on the importance of engaging people. We would like to thank all speakers and participants and look forward to the next forum in 2023.